The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Total neoadjuvant therapy followed by total mesorectal excision and selective lateral lymph node dissection for locoregionally advanced low rectal cancer: A phase III randomized controlled trial (JCOG2207).
 
Masayoshi Yasui
No Relationships to Disclose
 
Masayuki Ohue
No Relationships to Disclose
 
Senzo Taguchi
No Relationships to Disclose
 
Yoshinori Ito
No Relationships to Disclose
 
Toshihiro Kudo
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); Incyte Japan (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
 
Satoshi Ikeda
No Relationships to Disclose
 
Yasumasa Takii
No Relationships to Disclose
 
Manabu Shiozawa
Speakers' Bureau - Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hideki Ueno
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol Myers Squibb Foundation (Inst); Chugai Pharma (Inst); Incyte Japan (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Amgen - Local PI (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Shunsuke Tsukamoto
No Relationships to Disclose
 
Tadayoshi Hashimoto
Honoraria - Cytogen; Takata Pharmaceutical
 
Yusuke Sano
No Relationships to Disclose
 
Junki Mizusawa
Employment - Pfizer (I)
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; m3.com
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); ONO PHARMACEUTICAL (Inst)
 
Yukihide Kanemitsu
Honoraria - Covidien; Ethicon